Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 4363994: Measured Fontan conduit size and functional capacity: An analysis of the FORCE registry

View through CrossRef
Total cavo-pulmonary connection (Fontan) is the final stage of single ventricle palliation. In patients with an extracardiac (EC) Fontan, the synthetic conduit connecting the inferior vena cava to the pulmonary artery does not grow and may become smaller over time. We hypothesize that smaller measured Fontan conduit diameter will be associated with lower functional capacity as measured by percent predicted peak VO2 (ppVO2). A cross-sectional analysis of the FORCE registry was performed. Cardiac magnetic resonance imaging (CMR), exercise stress test (EST), and clinical data were extracted. Patients with EC-Fontan who had a CMR and EST within 1 year of each other from Jan 2003-June 2024 were included. Fontan conduits were manually segmented in 3D-Slicer. Center-line based assessments of conduit diameter were performed using circle-equivalent (CE) and maximum inscribed sphere (MIS) techniques (Figure 1). The relationships between minimum and length-averaged CE and MIS diameters indexed to body surface area (BSA) and percent predicted VO2 (ppVO2) were examined in bivariate and multivariable analyses, controlling for known predictors of exercise performance in Fontan patients: ventricular morphology, ventricular ejection fraction, atrioventricular valve regurgitation, time since Fontan, and presence of a patent fenestration. Adequate imaging was present in 393 patients, of these 311 patients from 27 contributing centers had complete data for EST and CMR analysis. The median age at the time of CMR was 15.5 years and the median time between CMR and EST was 61 days. The median ppVO2 was 59% (IQR 50-68%). The median minimum Fontan conduit diameters by MIS and CE respectively were 14.6mm (IQR 13.1-16.0mm) and 17.1mm (IQR 15.8-18.7mm), while the median length-averaged Fontan conduit diameters by MIS and CE were 16.1mm (IQR 14.7-17.3mm) and 18.5 (IQR 17.0-20.0mm) (Figure 2). After indexing to BSA all four measures were associated with ppVO2, but average MIS was slightly more predictive, so was used in the multivariable model (Figure 3). After controlling for the known predictors listed above, each mm/m2 increase in measured conduit diameter was associated with a 1.6% increase in ppVO2 (p<0.001). Fontan diameter is extremely variable across individuals. Smaller indexed Fontan conduit diameter is associated with lower functional capacity as measured by ppVO2. Further data is needed to determine if strategies to increase Fontan conduit size improve functional capacity.
Title: Abstract 4363994: Measured Fontan conduit size and functional capacity: An analysis of the FORCE registry
Description:
Total cavo-pulmonary connection (Fontan) is the final stage of single ventricle palliation.
In patients with an extracardiac (EC) Fontan, the synthetic conduit connecting the inferior vena cava to the pulmonary artery does not grow and may become smaller over time.
We hypothesize that smaller measured Fontan conduit diameter will be associated with lower functional capacity as measured by percent predicted peak VO2 (ppVO2).
A cross-sectional analysis of the FORCE registry was performed.
Cardiac magnetic resonance imaging (CMR), exercise stress test (EST), and clinical data were extracted.
Patients with EC-Fontan who had a CMR and EST within 1 year of each other from Jan 2003-June 2024 were included.
Fontan conduits were manually segmented in 3D-Slicer.
Center-line based assessments of conduit diameter were performed using circle-equivalent (CE) and maximum inscribed sphere (MIS) techniques (Figure 1).
The relationships between minimum and length-averaged CE and MIS diameters indexed to body surface area (BSA) and percent predicted VO2 (ppVO2) were examined in bivariate and multivariable analyses, controlling for known predictors of exercise performance in Fontan patients: ventricular morphology, ventricular ejection fraction, atrioventricular valve regurgitation, time since Fontan, and presence of a patent fenestration.
Adequate imaging was present in 393 patients, of these 311 patients from 27 contributing centers had complete data for EST and CMR analysis.
The median age at the time of CMR was 15.
5 years and the median time between CMR and EST was 61 days.
The median ppVO2 was 59% (IQR 50-68%).
The median minimum Fontan conduit diameters by MIS and CE respectively were 14.
6mm (IQR 13.
1-16.
0mm) and 17.
1mm (IQR 15.
8-18.
7mm), while the median length-averaged Fontan conduit diameters by MIS and CE were 16.
1mm (IQR 14.
7-17.
3mm) and 18.
5 (IQR 17.
0-20.
0mm) (Figure 2).
After indexing to BSA all four measures were associated with ppVO2, but average MIS was slightly more predictive, so was used in the multivariable model (Figure 3).
After controlling for the known predictors listed above, each mm/m2 increase in measured conduit diameter was associated with a 1.
6% increase in ppVO2 (p<0.
001).
Fontan diameter is extremely variable across individuals.
Smaller indexed Fontan conduit diameter is associated with lower functional capacity as measured by ppVO2.
Further data is needed to determine if strategies to increase Fontan conduit size improve functional capacity.

Related Results

On Flores Island, do "ape-men" still exist? https://www.sapiens.org/biology/flores-island-ape-men/
On Flores Island, do "ape-men" still exist? https://www.sapiens.org/biology/flores-island-ape-men/
<span style="font-size:11pt"><span style="background:#f9f9f4"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><spa...
Hubungan Perilaku Pola Makan dengan Kejadian Anak Obesitas
Hubungan Perilaku Pola Makan dengan Kejadian Anak Obesitas
<p><em><span style="font-size: 11.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-langua...
Abstract 4142149: A 10 Year Report on Fontan Candidacy
Abstract 4142149: A 10 Year Report on Fontan Candidacy
Background: As patients progress through the single ventricle palliation, changing hemodynamics and non-cardiac conditions can prevent completion of Fontan. We sought t...
A 10-Year Single Center Report on Fontan Attrition and Non-Fontan Candidacy
A 10-Year Single Center Report on Fontan Attrition and Non-Fontan Candidacy
Abstract Background: As patients progress through single ventricle (SV) palliation, changing hemodynamics and patient conditions can prevent progression to Fontan. We sough...
Abstract 15765: Clinical Significance of Submaximal Parameters of Exercise Stress Test in Characterizing Post-Fontan Patients
Abstract 15765: Clinical Significance of Submaximal Parameters of Exercise Stress Test in Characterizing Post-Fontan Patients
Background: Fontan patients have diminished exercise capacity relative to healthy peers. Peak oxygen consumption (pVO2) is a useful marker for maximum exercise capacity...
Fontan‐Associated Dyslipidemia
Fontan‐Associated Dyslipidemia
Background Hypocholesterolemia is a marker of liver disease, and patients with a Fontan circulation may have hypocholesterolemia secondary to Fontan‐associated liver di...
Outcome of Early and Late Onset Fontan Operation in Patients with Univentricular Heart Repair
Outcome of Early and Late Onset Fontan Operation in Patients with Univentricular Heart Repair
Objective: To determine the outcome of early and late-onset Fontan operation in patients with univentricular heart repair. Study Design: Quasi-experimental study. Place and Duratio...
Differences in Exercise Performance in Fontan Patients with Extracardiac Conduit and Lateral Tunnel: A FORCE Fontan Registry Study
Differences in Exercise Performance in Fontan Patients with Extracardiac Conduit and Lateral Tunnel: A FORCE Fontan Registry Study
Background: To explore the differences in exercise capacity between the extracardiac conduit (ECC) and lateral tunnel (LT) Fontan. Methods: 2169 patients (36% LT (n = 774); 64% ECC...

Back to Top